Permanent neonatal diabetes due to KCNJ11 gene mutation

被引:0
|
作者
S. Letha
Darly Mammen
Joseph J. Valamparampil
机构
[1] Government Medical College,Department of Pediatrics
来源
关键词
Permanent neonatal diabetes; KCN11 gene; Kir 6.2; Sulphonylurea; Glibenclamide;
D O I
暂无
中图分类号
学科分类号
摘要
Permanent neonatal diabetes mellitus (PNDM) is characterized by the onset of diabetes within the first six months of life and insulin dependence life long. It has been recently discovered that mutation in KCNJ11 gene encoding Kir6.2, the pore forming subunit of ATP sensitive potassium channel (KATP) is the most common cause and such patients may respond better to oral sulphonylurea drugs than insulin. Here is a rare case of permanent neonatal diabetes due to R201C mutation in KCNJ11 gene.
引用
收藏
页码:947 / 949
页数:2
相关论文
共 50 条
  • [21] KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes
    Massa, O
    Iafusco, D
    D'Amato, E
    Gloyn, AL
    Hattersley, AT
    Pasquino, B
    Tonini, G
    Dammacco, F
    Zanette, G
    Meschi, F
    Porzio, O
    Bottazzo, G
    Crinó, A
    Lorini, R
    Cerutti, F
    Vanelli, M
    Barbetti, F
    HUMAN MUTATION, 2005, 25 (01) : 22 - 27
  • [22] Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation
    Jesic, Milos M.
    Jesic, Maja D.
    Maglajlic, Svjetlana
    Sajic, Silvija
    Necic, Svetislav
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 91 (01) : E1 - E3
  • [23] Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide
    Bremer, Andrew A.
    Ranadive, Sayali
    Lustig, Robert H.
    PEDIATRIC DIABETES, 2008, 9 (03) : 236 - 239
  • [24] A CASE OF TRANSIENT NEONATAL DIABETES ASSOCIATED WITH A NOVEL KCNJ11 MUTATION
    Gole, Evangelia
    Oikonomou, Stavroula
    Karachaliou, Feneli
    Karavanaki, Kyriaki
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 343 - 343
  • [25] Long-term response to sulfonylurea in a patient with diabetes due to mutation in the KCNJ11 gene
    Vendramini, Marcio F.
    Gurgel, Lucimary C.
    Moises, Regina S.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2010, 54 (08) : 682 - 684
  • [26] Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes
    Babiker, Tarig
    Vedovato, Natascia
    Patel, Kashyap
    Thomas, Nicholas
    Finn, Roisin
    Mannikko, Roope
    Chakera, Ali J.
    Flanagan, Sarah E.
    Shepherd, Maggie H.
    Ellard, Sian
    Ashcroft, Frances M.
    Hattersley, Andrew T.
    DIABETOLOGIA, 2016, 59 (06) : 1162 - 1166
  • [27] Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes
    Tarig Babiker
    Natascia Vedovato
    Kashyap Patel
    Nicholas Thomas
    Roisin Finn
    Roope Männikkö
    Ali J. Chakera
    Sarah E. Flanagan
    Maggie H. Shepherd
    Sian Ellard
    Frances M. Ashcroft
    Andrew T. Hattersley
    Diabetologia, 2016, 59 : 1162 - 1166
  • [28] A Pathway to Insulin Independence: A Single Center's Experience with Permanent Neonatal Diabetes Due to Mutations in KCNJ11
    Hathout, Eba
    Chan, Nathaniel
    Ellard, Sian
    Young, Elizabeth
    Mace, John
    Njolstad, Pal
    Hattersley, Andrew
    DIABETES, 2010, 59 : A693 - A693
  • [29] Neonatal Diabetes Mellitus: Description of Two Puerto Rican Children with KCNJ11 Activating Gene Mutation
    Nieves-Rivera, Francisco
    Gonzalez-Pijem, Lilliam
    PUERTO RICO HEALTH SCIENCES JOURNAL, 2011, 30 (02) : 87 - 89
  • [30] Management of Neonatal Diabetes due to a KCNJ11 Mutation with Automated Insulin Delivery System and Remote Patient Monitoring
    Lee, Ming Yeh
    Gloyn, Anna L.
    Maahs, David M.
    Prahalad, Priya
    CASE REPORTS IN ENDOCRINOLOGY, 2023, 2023